Study suggests germ exposure may explain why first-born siblings achieve more
By
The Economist
You can taste the rush. The dough hadn't risen.
Summary
A new study suggests that birth order effects on success (first-borns achieving higher education and income) may be linked to germ exposure rather than personality differences. While stereotypes portray eldest children as responsible and younger ones as rebellious, large-scale studies find no meaningful connection between birth order and personality. Instead, the research points to biological factors—specifically, germs—as a potential explanation for why eldest siblings tend to outperform their younger counterparts on standard success measures.
Key quotes
· 4 pulledSORRY, YOUNGER siblings.
On standard measures of success, such as educational achievement and income, first-borns do better.
Stereotypes cast eldest children as responsible and younger ones as rebellious—but large-scale studies find no meaningful link between birth order and personality types.
New research points to something rather different: germs.
You might also wanna read
Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds
An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug blocks
Woman develops whiplike rash on back after eating shiitake mushrooms
A woman developed bright-red, whiplike rashes on her back after eating shiitake mushrooms, a condition known as shiitake dermatitis. The cas
livescience.com·3h agoMolecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
Molecular glue approach doubles survival time for aggressive pancreatic cancer patients
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds
An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug works b

Senolytic treatment linked to oligodendrocyte dysfunction and demyelination in brain study
This scientific research article investigates the effects of senolytic treatment (dasatinib and quercetin combination) on the corpus callosu
